Sari la conținut

Română · beta. Traducerea a fost făcută automat și este încă în curs de revizuire. Citește pagina în engleză

În afara temei aiqbench

În afara temei aiqbench

Această știre a fost preluată de la o sursă pe care o urmărim, dar nu ține de domeniul AI sau cuantic, așa că nu există o perspectivă aiqbench pentru ea.

A Point-of-Prescription Safety-Check System for Adverse Drug Reactions in Rural Bangladeshi Hospitals: A Feasibility Study

arXiv3 min de cititArticolul și perspectiva sunt în engleză.

arXiv:2608.27239v1 Announce Type: cross Abstract: Adverse drug reactions (ADRs) are a major, largely preventable source of patient harm. In high-income settings, electronic health records store a patient's allergy history and warn prescribers when a contraindicated drug is ordered; in rural Bangladeshi public hospitals no such record exists for outgoing patients, a single physician may see on the order of one patient per minute, and a patient's history of severe reactions does not survive between visits. This paper proposes and outlines the evaluation of a lightweight, smartphone-based safety-check system for this setting. At registration a soft identifier (a phone number) is recorded; after the physician writes a prescription, its image is captured, the brand names are resolved to active ingredients using national drug references, and the ingredients are matched against the patient's recorded severe reaction history. The system is retrieval-based rather than predictive, and is silent by default, raising a flag only for high-risk matches a design grounded in the alert-fatigue literature. We frame the work as a feasibility study: we describe the proposed framework and an evaluation plan measuring workflow fit under high volume, usability, identity-resolution reliability, and retrospective detection of known reaction cases. We explicitly do not claim a clinical-outcome effect, which the low base rate of severe events places beyond a single-site feasibility study.

Abstract:Adverse drug reactions (ADRs) are a major, largely preventable source of patient harm. In high-income settings, electronic health records store a patient's allergy history and warn prescribers when a contraindicated drug is ordered; in rural Bangladeshi public hospitals no such record exists for outgoing patients, a single physician may see on the order of one patient per minute, and a patient's history of severe reactions does not survive between visits. This paper proposes and outlines the evaluation of a lightweight, smartphone-based safety-check system for this setting. At registration a soft identifier (a phone number) is recorded; after the physician writes a prescription, its image is captured, the brand names are resolved to active ingredients using national drug references, and the ingredients are matched against the patient's recorded severe reaction history. The system is retrieval-based rather than predictive, and is silent by default, raising a flag only for high-risk matches a design grounded in the alert-fatigue literature. We frame the work as a feasibility study: we describe the proposed framework and an evaluation plan measuring workflow fit under high volume, usability, identity-resolution reliability, and retrospective detection of known reaction cases. We explicitly do not claim a clinical-outcome effect, which the low base rate of severe events places beyond a single-site feasibility study.

Human-Computer Interaction (cs.HC); Machine Learning (cs.LG)

arXiv:2608.27239 [cs.HC]

(or arXiv:2608.27239v1 [cs.HC] for this version)

https://doi.org/10.48550/arXiv.2608.27239 Focus to learn more arXiv-issued DOI via DataCite (pending registration)

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Text integral sub licența deschisă a publicației · 308 cuvinte

Subiecte conexe